Why BioNTech Stock Is Jumping Today

1 min read

Shares of BioNTech (NASDAQ: BNTX) were jumping 6.7% higher as of 11:03 a.m. EST on Monday. The gain came after a spokesperson for the European Commission confirmed that the commission is in discussions with BioNTech and its partner Pfizer (NYSE: PFE) about potentially ordering more doses of COVID-19 vaccine BNT162b2, marketed as Comirnaty.

The European Commission initially placed an order for 200 million doses of BNT162b2 in November 2020. In December, it exercised an option to obtain another 100 million doses of the vaccine. 

Image source: Getty Images.

Continue reading

Leave a Reply

Your email address will not be published.

Previous Story

Why Solar Energy Stocks Can Beat the Market Again in 2021

Next Story

3 Stocks to Watch in January

Latest from Blog